Press Release PR9.NET
Home Submit Press Release Search Archives
Press Release
Advanced Search
BROWSE BY CATEGORY

Health Health
Organizations
Dentistry, Education
Insurance, Medicine
Mental, Nutrition
Environmental Health
Resources, Weight Loss

Business Business
Computers Computers
Entertainment Entertainment
Games Games
Home Home
Science Science
Sports Sports
Society Society
Teens Teens
Press Release Category Health - Organizations - Center for Human Reproduction Release Date: July 11, 2010

Tel Aviv University Fertility Research Confirms New York Center's DHEA Findings


By Center for Human Reproduction
July 11, 2010
Send SEND Print PRINT Download PDF Version PDF Contact Center for Human Reproduction CONTACT

Tel Aviv University's recent findings on the supplementation of DHEA to improve fertility in women with diminished ovarian reserve further confirms Center For Human Reproduction's ongoing research on this treatment.

PR9.NET July 11, 2010 - New York, NY - A study conducted by Adrian Shulman, MD and co-workers of Tel Aviv University in Tel Aviv, Israel, confirmed previously published research by New York City's Center for Human Reproduction (CHR) about the positive effects of the supplement dehydroepiandrosterone (DHEA) in improving fertility in women with diminished ovarian reserve. Dr. Shulman's study, which featured only 33 women, 17 on DHEA and 16 controls, represents the first prospectively randomized study of DHEA in infertility. It confirmed prior published reports from CHR that DHEA increases the likelihood of conception with in vitro fertilization (IVF) approximately threefold.

New York's CHR pioneered the use of DHEA and has been using DHEA supplementation in women with diminished ovarian reserve since 2004. CHR researchers, under the leaderships of Norbert Gleicher, MD, the center's Medical Director, and David H. Barad, MD, its Director of Clinical Assisted Reproduction, previously published a number of controlled studies of various designs demonstrating the benefits of DHEA in increasing fertility in prestigious peer-reviewed medical journals – such as Fertility and Sterility, Human Reproduction and the Journal of Assisted Reproduction and Genetics – which contributed to the increasing popularity of DHEA supplementation world-wide. CHR's prior studies are, indeed, fully referenced in the scientific paper by Shulman and associates, though left unmentioned in the press release, accompanying publication of their study.

Based on prior research CHR, indeed, in 2009 was awarded a United States patent for the use of DHEA in treating infertility in women with diminished ovarian reserve. Over 2,000 women from all over the U.S. and the world so far received treatment with DHEA at CHR, either because of diminished ovarian reserve due to advanced age or premature ovarian aging. This comparatively very large experience contributes to CHR's world-wide reputation as a "fertility center of last resort."


By successfully recruiting 33 women into a prospectively randomized study, of which 17 received DHEA, Dr. Shulman's group achieved a key research milestone that CHR, despite several attempts over six years, failed to realize. As, however, quoted in their paper, but omitted by the paper's press release, researchers and physicians, including Dr. Shulman and associates, started utilizing DHEA worldwide only based on earlier CHR research and publications.

The study by Shulman and associates represents an important step forward in confirming the beneficial effects of DHEA in female infertility and the investigators are to be congratulated on their efforts. Further information about CHR's DHEA treatments and research can be found by visiting: http://www.centerforhumanreprod.com/dhea.html


# # #

Contact Information of Center for Human Reproduction Contact Information of Center for Human Reproduction
Phone (212) 994-4400
FAX (212) 994-4499
Website http://www.centerforhumanreprod.com
E-Mail E-mail Address Protected
Address 21 E. 69th Street
New York, NY 10021


About Center for Human Reproduction

About Center for Human Reproduction: Center for Human Reproduction (CHR) is one of the leading fertility centers in the United States. A provider of fertility services to both men and women, CHR is also a research and educational organization, holding a number of patents in the field of human fertility. More information about CHR can be found online by visiting www.centerforhumanreprod.com or by calling 212-994-4400.

Recent News Headlines
More Press Releases
Industry Category of Current Press Release
    Copyright © 2004 - 2014 PR9.NET - All rights reserved RSS Feeds Submit Press Release Terms of Service Privacy Policy